Generalized Myasthenia Gravis
📧 Sign up to get email alerts when something new happens for Generalized Myasthenia Gravis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-26Clinical Trial Update: A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis [Phase 2, Phase 3]
Clinical trial update for Rozanolixizumab in pediatric participants with moderate to severe generalized myasthenia gravis (Phase 2/Phase 3),…
-
CLINICAL_TRIALS trial_result · 2026-08-14Clinical Trial Update: A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis [Phase 2, Phase 3]
Clinical trial update for rozanolixizumab in pediatric participants with moderate to severe generalized myasthenia gravis (Phase 2/Phase 3; …
-
CLINICAL_TRIALS trial_result · 2026-08-12Clinical Trial Update: Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis [Phase 3]
Phase 3 open-label extension study of zilucoplan in generalized myasthenia gravis has completed.
-
CLINICAL_TRIALS trial_result · 2026-07-31Clinical Trial Update: A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis [Phase 2, Phase 3]
A pediatric study of rozanolixizumab for moderate to severe generalized myasthenia gravis is ongoing (Phase 2/Phase 3).
-
CLINICAL_TRIALS trial_result · 2026-07-20Clinical Trial Update: Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis [Phase 3]
Open-label extension study of zilucoplan in generalized myasthenia gravis is ongoing (Phase 3).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-06-29Clinical Trial Update: Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis [Phase 3]
Open-label extension trial of zilucoplan in generalized myasthenia gravis (Phase 3) is active/not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis [Phase 3]
Phase 3 clinical trial evaluating batoclimab for induction and maintenance therapy in adults with generalized myasthenia gravis.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis [Phase 2, Phase 3]
A pediatric study evaluating efgartigimod PH20 SC in children aged 2 to under 18 with generalized myasthenia gravis is in Phase 2/Phase 3 an…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis [Phase 3]
Phase 3 trial update for ALXN1720 evaluating safety and efficacy in adults with Generalized Myasthenia Gravis; the study is currently active…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Evaluation of PK, PD, Efficacy, Safety, and Immunogenicity of IV Ravulizumab in Pediatric Participants With Generalized Myasthenia Gravis [Phase 3]
Ongoing Phase 3 trial evaluating ravulizumab in pediatric participants with generalized myasthenia gravis, assessing pharmacokinetics, pharm…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis [Phase 3]
This clinical trial update discusses an extension study of Rozanolixizumab in pediatric Generalized Myasthenia Gravis patients, evaluating 6…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis [Phase 1, Phase 2]
A Phase 1/2 clinical trial to assess safety, efficacy, and cellular kinetics of YTB323 in generalized myasthenia gravis is currently recruit…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia Gravis [Phase 3]
Phase 3 study update on the safe and effective use of a zilucoplan auto-injector in adults with generalized myasthenia gravis; results have …
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis [Phase 3]
A Phase 3 clinical trial update evaluating safety and efficacy of Pozelimab with Cemdisiran combination and Cemdisiran alone in adults with …
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously in Patients With Generalized Myasthenia Gravis [Phase 3]
Phase 3 long-term safety and tolerability results for subcutaneous efgartigimod PH20 in Generalized Myasthenia Gravis have been reported.
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Eculizumab in Chinese Adults With gMG [Phase 3]
Phase 3 study evaluating the efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of eculizumab in Chinese adults with g…
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimod IV in Patients With Generalized Myasthenia Gravis [Phase 3]
An open-label Phase 3 study evaluating different dosing regimens of efgartigimod IV in generalized myasthenia gravis has been completed.
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis [Phase 3]
A Phase 3 trial evaluating Rozanolixizumab in adults with Generalized Myasthenia Gravis has completed, and the study results were posted on …
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: An Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in Participants With Generalized Myasthenia Gravis Who Were Previously Receiving Intravenous Complement Component 5 Inhibitors [Phase 3]
Open-label Phase 3 study evaluating subcutaneous zilucoplan in generalized myasthenia gravis patients previously treated with IV C5 inhibito…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis [Phase 3]
Phase 3 study evaluating satralizumab in generalized myasthenia gravis was terminated. Results from the trial have been posted.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis [Phase 3]
Phase 3 clinical trial evaluating Rozanolixizumab in adults with generalized myasthenia gravis has completed. The study results have been po…
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis [Phase 3]
Phase 3 study evaluating long-term safety, tolerability, and efficacy of rozanolixizumab in adults with generalized myasthenia gravis has co…
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Evaluating the Pharmacodynamic Noninferiority of Efgartigimod PH20 SC Administered Subcutaneously as Compared to Efgartigimod Administered Intravenously in Patients With Generalized Myasthenia Gravis [Phase 3]
A Phase 3 trial assessing pharmacodynamic noninferiority of Efgartigimod PH20 SC versus IV in generalized myasthenia gravis has completed wi…
-
CLINICAL_TRIALS trial_result · 2022-06-27Clinical Trial Update: Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis [Phase 2]
Phase 2 trial evaluating RA101495 in generalized myasthenia gravis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-05-26Clinical Trial Update: Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis [Phase 3]
Phase 3 safety and efficacy study of Ravulizumab in adults with Generalized Myasthenia Gravis completed and results posted. The trial assess…